Table Of Content

AUTHOR INDEX TO VOLUME 55 Abdullaev FI, 113 Matilla A, 235 Abuhijleh AL, 255 Matsumura K, 153 Alonso C, 235 Mernissi-Arifi K, 263 Alzuet G, 147 Miyazaki M, 123 Bal W, 41 Molenda JJ, 131 Basinger MA, 131 Niclés-Gutiérrez J, 235 Bertalan C, 67 Nyeki O, 67 Borras J, 147 Ozawa T, 123 Chifotides HT, 203 Pérez JM, 235 Ding M, 101 Perlepes SP, 217 Ducros V, 157 Pettit LD, 41 Dunbar KR, 203 Pezeshk A, 1 Dung N-H, 235 Pneumatikakis G, 203 Farrell N, 79 Pursiainen J, 53 Favier A, 157 Ramappa PG, 13 Ferrer S, 147 Richard MJ, 157 Frenkel GD, 113 Riddell FG, 279 FujiwaraY , 123 Robbins R, 41 Gannett PM, 101 Rojanasakul Y, 101 Gilman H, 21, 31 Rowatt E, 249 Glass RS, 87 Safavi A, 41 G6bI L, 67 Sakurai T, 193 Hambley TW, 175 Sanaullah, 87 Hanusa TP, 131 Schlewer G, 263 Hille R, 295 Schon I, 67 Hondrellis V, 217 Shi J, 165 Hukins DWL, 21, 31 Shi X, 101 JiangY , 165 Soares Fontes AP, 79 Jones MM, 131 Somasekharappa KG, 13 Katsaros N, 203 Sorenson JRJ, 147 Kim JH, 295 Sovag6 I, 53, 67 Kiss T, 53 Spiess B, 263 Komiyama M, 153 Subczynski WK, | Kozlowski H, 41 Tercero JM, 235 Liao Z, 165 Tsangaris JM, 217 Lisowski M, 41 Ueda J-i, 123 Liu C, 165 Viossat B, 235 Liu J, 165 Webster LK, 175 Liu K, 101 Wehrer C, 263 Liu W, 165 Williams RJP, 249 Manessi-Zoupa E, 217 Wilson GS, 87 Maret W, 77 Wojas J, 1 Martin-Ramos JD, 235 Zhou Z, 279 Martin RB, 53 Zou Y, 79 Massoud SS, 183 305 SUBJECT INDEX TO VOLUME 55 Adenosine 5'-triphosphate (ATP), aqua-amine-cobalt(II1) Ibuprofen, mononuclear and binuclear copper(II) complexes complexes and, 183 of, 255 Albumin, hydroxyapatite, seeded growth in, 21, 31 Inositol-phosphates, complexation studies on, 263 Alkali metal ions, NMR studies and, 263 Iron(III), 3-hydroxypyrid-4-ones and, 131 Alkyl chains, probucol and, | Iron(II1) chloride, diphenylpyraline complexes of, 13 Aluminum, phosvitin and, 249 lron(III) nitrate, diphenylpyraline complexes of, 13 Aluminum(II1)-adenosine-5'-phosphates, ternary complex lron(III1) sulphate, diphenylpyraline complexes of, 13 formation with carboxylic acid derivatives and, 53 Iron(III) thiocyanate, diphenylpyraline complexes of, 13 Alzheimer’s disease, aluminum in, 249 Kojic acid, hydrophilic derivatives of, 131 Amide groups, ligands containing, 217 Leukemia, P388, L- and D-[Pt(O-Methyl-methionine)Cl,] Anticonvulsant agents against, 175 acetazolamide, 147 Ligands, amide groups in, 217 copper acetazolamide complexes, 147 Lipid peroxidation, probucol and, | Antiinflammatory agents, copper(II) complexes of, 255 Manganese’, contrast reagent for NMR studies, 263 Antimicrobial activity, in iron(II1) complexes, 13 Mercaptopurine, mercury(I) and methylmercury(II) com- Antitumor studies, cis-dichloro-palladium(II) complexes plexes of azathioprine, 203 with diaminosuccinic acid, 235 Mercury(II), azathioprine complexes of, 203 Aqua-amine-cobalt(III) complexes, adenosine 5'-triphos- Metal complexes phate (ATP) hydrolysis by, 183 N-(2-Benzamide)pyridine-2'-carboxamide, 217 Ascorbate, one-electron reduction of vanadate with, 101 bio-peptides and, 41 Ascorbate oxidase, electron-transfer reactions, 193 Metal ions Azathioprine, mercury(II) and methylmercury(II) com- NMR studies and, 263 plexes of, 203 phosphatidylinositol hydrolysis by rare earth, 153 N-(2-Benzamide)pyridine-2'-carboxamide, transition metal phosphatidylinositol hydrolysis by rare earth metal ion, complexes of, 217 153 Bio-peptides, copper(II) interaction with, 41 Methionine, redox chemistry of, 87 Bromide, NMR studies with, 263 O-Methyl-methionine dichloroplatinum(II), L and D enan- Caffeine adducts, ibuprofen and, 255 tiomers of, 175 Calcium, hydroxyapatite in dissolved albumin and, 21, 31 Methylmercury(II), azathioprine complexes of, 203 Carboxylic acid derivatives, ternary complex formation with Metronidazole, ibuprofen and, 255 aluminum(II1)-adenosine-5'-phosphates and, 53 Myo-inositol triphosphates, protonation and complexation Chloride, NMR studies with, 263 properties of, 263 Chrome azurol S, aluminum measurements with, 249 N,N,N’,N’-tetrakis (2'-benzimidazolyl methyl)-1,4- cis-Dichloro-palladium(I]) complexes, diaminosuccinic diethylene amino glycol ether (EGTB), superoxide acid and its diethyl ester in, 235 dismutase (SOD)-like activity of, 165 Contrast reagent, NMR studies with manganese”’ as, 263 Nucleic acid synthesis, selenite inhibition of, 113 Copper acetazolamide complexes, anticonvulsant proper- Palladium-diaminosuccinic acid complexes, 235 ties of, 147 Phosphatidylcholine membranes, probucol and, | Copper(I1), bio-peptides and, 41 Phosphatidylinositol, rare earth metal ion hydrolysis of, 153 Copper(II) complexes Phospholipase C mimic, phosphatidylinositol hydrolysis by hydrogen peroxide activation by, 123 rare earth metal ion as, 153 of ibuprofen, 255 Phosvitin, aluminum and, 249 of thymopoietin derivatives, 67 Plasma proteins, time course of selenium labeled, 157 Crystal growth, hydroxyapatite in dissolved albumin, 21, Platinum complexes, synthesis of functionalized, 79 31 Probucol Cytochrome c, electron-transfer reactions, 193 lipid peroxidation and, | Dehydromethionine, methionine oxidation and, 87 phosphatidylcholine membranes and, | Diaminosuccinic acid, cis-dichloro-palladium(II) com- SDS micelles, copper(II) interaction with bio-peptides and, plexes with, 235 41 Dimethylsulfoxide, synthesis of functionalized platinum Selenite, cellular nucleic acid synthesis by, 113 complexes with, 79 Selenium, human plasma proteins and, 157 Diphenylpyraline complexes, iron(III), 13 Selenoproteins, 157 Electron paramagnetic resonance studies, substrate bind- Spectroscopic studies ing to xanthine oxidase, 295 copper(II) complexes of thymopoietin derivatives, 67 Electron spin resonance spin trapping methods, hydrogen copper(II) interaction with bio-peptides, 41 peroxide activation of copper(II) complexes, 123 mercury(II) and methylmercury(II) complexes of Electron-transfer, from cytochrome c to ascorbate oxidase, azathioprine, 203 193 superoxide dismutase (SOD) activity, 165 Glutathione peroxidase, 157 ternary complex formation with aluminum(II1)-adenos- Halide ions, NMR studies with, 263 ine-5'-phosphates and carboxylic acid derivatives, Hydrogen peroxide, copper(II) complexes in activation of, 53 123 vanadate, one-electron reduction of, 101 Hydroxyapatite, seeded growth in albumin, 21, 31 Spin-labeled adenine derivative, substrate binding to xan- 3-Hydroxypyrid-4-ones, synthesis and iron(III) binding of, thine oxidase and, 295 131 Spin labeling methods, probucol and, | 307 308 SUBJECT INDEX Substrate binding, xanthine oxidase in, 295 Thioethers, methionine oxidation and, 87 Sulfhydryl compounds, selenite and, 113 Thymopoietin, copper(II) complexes of, 67 Superoxide dismutase (SOD)-like activity of, N,N,N’,N’- Transition metal complexes, N-(2-Benzamide)pyridine-2'- tetrakis (2'-benzimidazolyl methyl)-1,4-diethylene carboxamide, 217 amino glycol ether (EGTB), 165 Vanadate, ascorbate in one-electron reduction of, 101 Ternary complex formation, aluminum(III)-adenosine-S'- Vanadium(V), ascorbate in one-electron reduction of, 101 phosphates and carboxylic acid derivatives in, 53 Vitamin E, probucol and, | Thiobarbituric acid methods, hydrogen peroxide activation Xanthine oxidase, substrate binding to, 295 of copper(II) complexes, 123 Z form, platinum complexes, synthesis of functionalized,